BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34724962)

  • 1. Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals.
    Talon I; Janiszewski A; Theeuwes B; Lefevre T; Song J; Bervoets G; Vanheer L; De Geest N; Poovathingal S; Allsop R; Marine JC; Rambow F; Voet T; Pasque V
    Genome Biol; 2021 Nov; 22(1):302. PubMed ID: 34724962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of the inactive X chromosome in development and reprogramming.
    Ohhata T; Wutz A
    Cell Mol Life Sci; 2013 Jul; 70(14):2443-61. PubMed ID: 23052214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights into X-Chromosome Reactivation during Reprogramming to Pluripotency.
    Panda A; Zylicz JJ; Pasque V
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming.
    Janiszewski A; Talon I; Chappell J; Collombet S; Song J; De Geest N; To SK; Bervoets G; Marin-Bejar O; Provenzano C; Vanheer L; Marine JC; Rambow F; Pasque V
    Genome Res; 2019 Oct; 29(10):1659-1672. PubMed ID: 31515287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-Chromosome Dosage Modulates Multiple Molecular and Cellular Properties of Mouse Pluripotent Stem Cells Independently of Global DNA Methylation Levels.
    Song J; Janiszewski A; De Geest N; Vanheer L; Talon I; El Bakkali M; Oh T; Pasque V
    Stem Cell Reports; 2019 Feb; 12(2):333-350. PubMed ID: 30639215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation.
    Gontan C; Achame EM; Demmers J; Barakat TS; Rentmeester E; van IJcken W; Grootegoed JA; Gribnau J
    Nature; 2012 Apr; 485(7398):386-90. PubMed ID: 22596162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ordered chromatin changes and human X chromosome reactivation by cell fusion-mediated pluripotent reprogramming.
    Cantone I; Bagci H; Dormann D; Dharmalingam G; Nesterova T; Brockdorff N; Rougeulle C; Vallot C; Heard E; Chaligne R; Merkenschlager M; Fisher AG
    Nat Commun; 2016 Aug; 7():12354. PubMed ID: 27507283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X Chromosome Dosage Influences DNA Methylation Dynamics during Reprogramming to Mouse iPSCs.
    Pasque V; Karnik R; Chronis C; Petrella P; Langerman J; Bonora G; Song J; Vanheer L; Sadhu Dimashkie A; Meissner A; Plath K
    Stem Cell Reports; 2018 May; 10(5):1537-1550. PubMed ID: 29681539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell landscape of nuclear configuration and gene expression during stem cell differentiation and X inactivation.
    Bonora G; Ramani V; Singh R; Fang H; Jackson DL; Srivatsan S; Qiu R; Lee C; Trapnell C; Shendure J; Duan Z; Deng X; Noble WS; Disteche CM
    Genome Biol; 2021 Sep; 22(1):279. PubMed ID: 34579774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early reactivation of clustered genes on the inactive X chromosome during somatic cell reprogramming.
    Aizawa S; Nishimura K; Mondejar GS; Kumar A; Bui PL; Tran YTH; Kuno A; Muratani M; Kobayashi S; Nabekura T; Shibuya A; Sugihara E; Sato TA; Fukuda A; Hayashi Y; Hisatake K
    Stem Cell Reports; 2022 Jan; 17(1):53-67. PubMed ID: 34919813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific analysis of cell fusion-mediated pluripotent reprograming reveals distinct and predictive susceptibilities of human X-linked genes to reactivation.
    Cantone I; Dharmalingam G; Chan YW; Kohler AC; Lenhard B; Merkenschlager M; Fisher AG
    Genome Biol; 2017 Jan; 18(1):2. PubMed ID: 28118853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome compartments on the inactive X guide TAD formation independently of transcription during X-reactivation.
    Bauer M; Vidal E; Zorita E; Üresin N; Pinter SF; Filion GJ; Payer B
    Nat Commun; 2021 Jun; 12(1):3499. PubMed ID: 34108480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human X chromosome inactivation and reactivation: implications for cell reprogramming and disease.
    Cantone I; Fisher AG
    Philos Trans R Soc Lond B Biol Sci; 2017 Nov; 372(1733):. PubMed ID: 28947657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Analysis Reveals Partial Reactivation of X Chromosome instead of Chromosome-wide Dampening in Naive Human Pluripotent Stem Cells.
    Mandal S; Chandel D; Kaur H; Majumdar S; Arava M; Gayen S
    Stem Cell Reports; 2020 May; 14(5):745-754. PubMed ID: 32359444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin connections to pluripotency and cellular reprogramming.
    Orkin SH; Hochedlinger K
    Cell; 2011 Jun; 145(6):835-50. PubMed ID: 21663790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
    Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastic dosage compensation by X-chromosome upregulation.
    Lentini A; Cheng H; Noble JC; Papanicolaou N; Coucoravas C; Andrews N; Deng Q; Enge M; Reinius B
    Nat Commun; 2022 Apr; 13(1):1854. PubMed ID: 35388014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early loss of Xist RNA expression and inactive X chromosome associated chromatin modification in developing primordial germ cells.
    de Napoles M; Nesterova T; Brockdorff N
    PLoS One; 2007 Sep; 2(9):e860. PubMed ID: 17848991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage compensation in the process of inactivation/reactivation during both germ cell development and early embryogenesis in mouse.
    Li X; Hu Z; Yu X; Zhang C; Ma B; He L; Wei C; Wu J
    Sci Rep; 2017 Jun; 7(1):3729. PubMed ID: 28623283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming.
    Generoso SF; Neguembor MV; Hershberg EA; Sadreyev RI; Kurimoto K; Yabuta Y; Ricci R; Audergon P; Bauer M; Saitou M; Hochedlinger K; Beliveau BJ; Cosma MP; Lee JT; Payer B
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2213810120. PubMed ID: 36669113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.